The A-share market continued its rebound on Tuesday, with the benchmark indexes buoyed by a price rally among large-cap shares and certain consumer-related sectors.
The top three major telecommunication carriers all reported rising revenues and profits in the first half of the year, despite the challenges posed by nationwide moves to boost internet speeds and reduce costs.
China's major nonferrous companies experienced a profitability surge in the first half of 2018, with analysts forecasting the industry's prospects are likely to remain promising throughout the year.
Online education is gaining momentum in China with the market scale expected to exceed 714 billion yuan ($104 billion) by 2025, a recent report from UBS Securities said.
BEIJING - Fast developing e-commerce has helped boost sales of used cars in China, as the online secondhand market gains in quality and variety.
BEIJING - Chinese consumers' demand for imported food has been growing steadily as the standard of living in China improves, according to a statement from the General Administration of Customs.
GUANGZHOU - Xinsha Customs in Dongguan, South China's Guangdong province, has seen a surge in customs declarations of imported automobiles since July.
Chinese mainland stocks rebounded on Monday, with communication and software shares leading the rise, and analysts identified structural investment opportunities for the short and mid term.
Unconventional reservoir technologies and data analytics are key to boosting oil and gas exploration and production in China, according to a senior executive of United States energy company ConocoPhillips.
Beijing ThunderStone Technology Co Ltd, China's leading karaoke system supplier by market share, announced it has completed a nearly 200 million yuan ($29 million) series B fundraising round, amid growing demand in the entertainment industry.
The Association of Southeast Asian Nations, a bloc that constitutes China's third largest trading partner, will exploit a variety of opportunities to further tap China's market, given the encouraging bilateral trade performance last year, an official said.
Bristol-Myers Squibb Co Ltd, a global biopharmaceutical company, will launch the first immuno-oncology cancer treatment product in China, aiming to become more diversified and specialized in the Chinese market, the company's top management said.
|
|
|
|
|
|
|
|
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
Raymond Zhou
Op Rana
Berlin Fang
Zhu Yuan
Huang Xiangyang
Chen Weihua
